A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients

Iris J. H. van Vlodrop; Sophie C. Joosten; Tim De Meyer; Kim M. Smits; Leander Van Neste; Veerle Melotte; Marcella M. L. L. Baldewijns; Leo J. Schouten; Piet A. van den Brandt; Jana Jeschke; Joo Mi Yi; Kornel E. Schuebel; Nita Ahuja; James G. Herman; Maureen J. Aarts; Fred T. Bosman; Wim Van Criekinge; Manon van Engeland

doi:10.1158/1078-0432.CCR-16-1236

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients

Iris J. H. van Vlodrop, Sophie C. Joosten, Tim De Meyer, Kim M. Smits, Leander Van Neste, Veerle Melotte, Marcella M. L. L. Baldewijns, Leo J. Schouten, Piet A. van den Brandt, Jana Jeschke, Joo Mi Yi, Kornel E. Schuebel, Nita Ahuja, James G. Herman, Maureen J. Aarts, Fred T. Bosman, Wim Van Criekinge, Manon van Engeland^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2006-2018
Number of pages	13
Journal	Clinical Cancer Research
Volume	23
Issue number	8
DOIs	https://doi.org/10.1158/1078-0432.CCR-16-1236
Publication status	Published - 15 Apr 2017

Keywords

CPG ISLAND HYPERMETHYLATION
HIPPEL-LINDAU GENE
CARCINOMA
MUTATIONS
EXPRESSION
PROGNOSIS
INACTIVATION
NETHERLANDS
EVOLUTION
RECEPTOR

Access to Document

10.1158/1078-0432.CCR-16-1236

Cite this

van Vlodrop, I. J. H., Joosten, S. C., De Meyer, T., Smits, K. M., Van Neste, L., Melotte, V., Baldewijns, M. M. L. L., Schouten, L. J., van den Brandt, P. A., Jeschke, J., Yi, J. M., Schuebel, K. E., Ahuja, N., Herman, J. G., Aarts, M. J., Bosman, F. T., Van Criekinge, W., & van Engeland, M. (2017). A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients. Clinical Cancer Research, 23(8), 2006-2018. https://doi.org/10.1158/1078-0432.CCR-16-1236

van Vlodrop, Iris J. H. ; Joosten, Sophie C. ; De Meyer, Tim ; Smits, Kim M. ; Van Neste, Leander ; Melotte, Veerle ; Baldewijns, Marcella M. L. L. ; Schouten, Leo J. ; van den Brandt, Piet A. ; Jeschke, Jana ; Yi, Joo Mi ; Schuebel, Kornel E. ; Ahuja, Nita ; Herman, James G. ; Aarts, Maureen J. ; Bosman, Fred T. ; Van Criekinge, Wim ; van Engeland, Manon. / A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients. In: Clinical Cancer Research. 2017 ; Vol. 23, No. 8. pp. 2006-2018.

@article{ec3010df9742417a8d5070dfff3e40e4,

title = "A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients",

keywords = "CPG ISLAND HYPERMETHYLATION, HIPPEL-LINDAU GENE, CARCINOMA, MUTATIONS, EXPRESSION, PROGNOSIS, INACTIVATION, NETHERLANDS, EVOLUTION, RECEPTOR",

author = "{van Vlodrop}, {Iris J. H.} and Joosten, {Sophie C.} and {De Meyer}, Tim and Smits, {Kim M.} and {Van Neste}, Leander and Veerle Melotte and Baldewijns, {Marcella M. L. L.} and Schouten, {Leo J.} and {van den Brandt}, {Piet A.} and Jana Jeschke and Yi, {Joo Mi} and Schuebel, {Kornel E.} and Nita Ahuja and Herman, {James G.} and Aarts, {Maureen J.} and Bosman, {Fred T.} and {Van Criekinge}, Wim and {van Engeland}, Manon",

year = "2017",

month = apr,

day = "15",

doi = "10.1158/1078-0432.CCR-16-1236",

language = "English",

volume = "23",

pages = "2006--2018",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}

van Vlodrop, IJH, Joosten, SC, De Meyer, T, Smits, KM, Van Neste, L, Melotte, V, Baldewijns, MMLL, Schouten, LJ , van den Brandt, PA, Jeschke, J, Yi, JM, Schuebel, KE, Ahuja, N, Herman, JG, Aarts, MJ, Bosman, FT, Van Criekinge, W & van Engeland, M 2017, 'A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients', Clinical Cancer Research, vol. 23, no. 8, pp. 2006-2018. https://doi.org/10.1158/1078-0432.CCR-16-1236

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients. / van Vlodrop, Iris J. H.; Joosten, Sophie C.; De Meyer, Tim; Smits, Kim M.; Van Neste, Leander; Melotte, Veerle; Baldewijns, Marcella M. L. L.; Schouten, Leo J.; van den Brandt, Piet A.; Jeschke, Jana; Yi, Joo Mi; Schuebel, Kornel E.; Ahuja, Nita; Herman, James G.; Aarts, Maureen J.; Bosman, Fred T.; Van Criekinge, Wim; van Engeland, Manon.

In: Clinical Cancer Research, Vol. 23, No. 8, 15.04.2017, p. 2006-2018.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients

AU - van Vlodrop, Iris J. H.

AU - Joosten, Sophie C.

AU - De Meyer, Tim

AU - Smits, Kim M.

AU - Van Neste, Leander

AU - Melotte, Veerle

AU - Baldewijns, Marcella M. L. L.

AU - Schouten, Leo J.

AU - van den Brandt, Piet A.

AU - Jeschke, Jana

AU - Yi, Joo Mi

AU - Schuebel, Kornel E.

AU - Ahuja, Nita

AU - Herman, James G.

AU - Aarts, Maureen J.

AU - Bosman, Fred T.

AU - Van Criekinge, Wim

AU - van Engeland, Manon

PY - 2017/4/15

Y1 - 2017/4/15

KW - CPG ISLAND HYPERMETHYLATION

KW - HIPPEL-LINDAU GENE

KW - CARCINOMA

KW - MUTATIONS

KW - EXPRESSION

KW - PROGNOSIS

KW - INACTIVATION

KW - NETHERLANDS

KW - EVOLUTION

KW - RECEPTOR

U2 - 10.1158/1078-0432.CCR-16-1236

DO - 10.1158/1078-0432.CCR-16-1236

M3 - Article

VL - 23

SP - 2006

EP - 2018

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 8

ER -